Skip to main content
Canna~Fangled Abstracts

Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells

By May 7, 2021June 6th, 2021No Comments
Review

doi: 10.3390/cells10051124.

Affiliations 

Free PMC article

Abstract

Neuronal survival depends on the glia, that is, on the astroglial and microglial support. Neurons die and microglia are activated not only in neurodegenerative diseases but also in physiological aging. Activated microglia, once considered harmful, express two main phenotypes: the pro-inflammatory or M1, and the neuroprotective or M2. When neuroinflammation, i.e., microglial activation occurs, it is important to achieve a good M1/M2 balance, i.e., at some point M1 microglia must be skewed into M2 cells to impede chronic inflammation and to afford neuronal survival. G protein-coupled receptors in general and adenosine receptors in particular are potential targets for increasing the number of M2 cells. This article describes the mechanisms underlying microglial activation and analyzes whether these cells exposed to a first damaging event may be ready to be preconditioned to better react to exposure to more damaging events. Adenosine receptors are relevant due to their participation in preconditioning. They can also be overexpressed in activated microglial cells. The potential of adenosine receptors and complexes formed by adenosine receptors and cannabinoids as therapeutic targets to provide microglia-mediated neuroprotection is here discussed.

 

Keywords: Alzheimer’s disease, Parkinson’s disease, aging, cannabinoids, neurodegeneration, neuronal survival, neuroprotection, receptor heteromers

Conflict of interest statement

Authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1

Figure 2

References

    1. Liu B., Teschemacher A.G., Kasparov S. Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders. Glia. 2017;65:1205–1226. doi: 10.1002/glia.23136. – DOI – PMC – PubMed
    1. Kwon H.S., Koh S.-H. Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes. Transl. Neurodegener. 2020;9:1–12. doi: 10.1186/s40035-020-00221-2. – DOI – PMC – PubMed
    1. Dipatre P.L., Gelman B.B. Microglial cell activation in aging and Alzheimer disease: Partial linkage with neurofibrillary tangle burden in the hippocampus. J. Neuropathol. Exp. Neurol. 1997;56:143–149. doi: 10.1097/00005072-199702000-00004. – DOI – PubMed
    1. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer’s disease. Neurobiol. Aging. 1988;9:339–349. doi: 10.1016/S0197-4580(88)80079-4. – DOI – PubMed
    1. Streit W.J., Sparks D.L. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J. Mol. Med. 1997;75:130–138. doi: 10.1007/s001090050097. – DOI – PubMed

Publication types

LinkOut – more resources


Leave a Reply